Stability Testing Services: Market Size & Forecast 2026

The global stability testing services market stands at approximately USD 4.2 billion in 2025 (base year), growing to roughly USD 7.7 billion by 2032 on a 7.8% CAGR, held in a structurally tight balance between expanding biologic drug pipelines, tightening ICH regulatory requirements, and chronic chamber-capacity constraints at mid-tier providers. A representative full ICH long-term plus accelerated stability protocol prices in the order of USD 18,500 per study, with direct labor and controlled-environment chamber depreciation accounting for 60% of delivered cost. North America leads with an estimated 45% regional share, but Asia-Pacific is the fastest-growing demand pocket at roughly 10% CAGR, driven by CDMO expansion in India and China. > **Analyst Take.** The 7.8% consensus CAGR is directionally right but the composition is wrong: biologics-driven protocol complexity, not volume, is th

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.